株式会社ジーエヌアイグループ 2024年12月期 第１四半期 決算説明資料

This document is the Q1 financial results presentation for the fiscal year ending December 2024 of GNI Group Ltd. It includes an overview of the company, highlights of the financial results, and forecasts for the current fiscal year. Notably, revenue increased by 41.4% compared to the same period last year, and operating profit surged by 474.4%. The document also discusses key products and business developments, emphasizing the company's growth strategy in global pharmaceutical research, development, manufacturing, and distribution. GNI Group aims to provide new hope to patients through the development of new drugs that meet unmet medical needs.